This website is designed to provide you with information about the study, Treatment of depression with onabotulinumtoxinA: A randomized, double-blind, placebo controlled trial. It should not be used as a substitute for professional medical diagnosis or treatment. The use of botulinum toxin to treat depression is currently in the investigational stages. It is not FDA approved for this indication. We welcome more research in this area, and shall post new developments as they arise.
Links to third party pages are provided for convenience only. We do not express any opinion on the content of any third party pages and expressly disclaim any liability for all third party information and the use of it.